Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

ganitumab

DRUG

capecitabine

DRUG

gemcitabine hydrochloride

RADIATION

3-dimensional conformal radiation therapy

Trial Locations (10)

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

19713

CCOP - Christiana Care Health Services, Newark

40202

James Graham Brown Cancer Center at University of Louisville, Louisville

92868

St. Joseph Hospital Regional Cancer Center - Orange, Orange

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

44309-2090

Summa Center for Cancer Care at Akron City Hospital, Akron

19612-6052

McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center, Reading

02903

Rhode Island Hospital Comprehensive Cancer Center, Providence

02904

Northmain Radiation Oncology, Providence

77030-4009

M. D. Anderson Cancer Center at University of Texas, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

NRG Oncology

OTHER

lead

Radiation Therapy Oncology Group

NETWORK